Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

BioCorRx (BICX) Cost of Revenue (2016 - 2024)

BioCorRx (BICX) has disclosed Cost of Revenue for 15 consecutive years, with $1667.0 as the latest value for Q1 2024.

  • Quarterly Cost of Revenue fell 80.79% to $1667.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $1667.0 through Dec 2024, down 95.37% year-over-year, with the annual reading at $1667.0 for FY2024, 95.37% down from the prior year.
  • Cost of Revenue hit $1667.0 in Q1 2024 for BioCorRx, down from $13053.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $28954.0 in Q4 2020 to a low of $632.0 in Q1 2021.
  • Historically, Cost of Revenue has averaged $9103.6 across 5 years, with a median of $3881.0 in 2023.
  • Biggest five-year swings in Cost of Revenue: soared 713.26% in 2020 and later plummeted 97.24% in 2021.
  • Year by year, Cost of Revenue stood at $28954.0 in 2020, then crashed by 91.6% to $2431.0 in 2021, then soared by 256.89% to $8676.0 in 2022, then soared by 50.45% to $13053.0 in 2023, then tumbled by 87.23% to $1667.0 in 2024.
  • Business Quant data shows Cost of Revenue for BICX at $1667.0 in Q1 2024, $13053.0 in Q4 2023, and $3881.0 in Q3 2023.